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Abstract--The neurofibromatosis type 1 (NF1) gene was recently identified by positional cloning 
and found to encode a protein with structural and functional homology to mammalian and yeast 
GTPase-activating proteins (GAPs). Using antibodies directed against the NF1 gene product, a 
protein of ~ 250 kDa was identified and termed neurofibromin. Double-indirect immunofluores- 
cent labeling with anti-neurofibromin and anti-tubulin antibodies demonstrates that neurofibro- 
min associates with cytoplasmic microtubules. Immunoblotting of  microtubule-enriched cytoplas- 
mic fractions, using antibodies generated against neurofibromin, shows that neurofibromin 
copurifes with microtubules. When portions of neurofibromin are expressed in Sf  9 insect cells they 
associate with polymerized microtubules; furthermore, the critical residues for this interaction 
reside within the GAP-related domain of  neurofibromin. The unexpected association of  neurofibro- 
min with microtubules suggests that neurofibromin is involved in microtubule-mediated intraceltu- 
lar signal transduction pathways. 
INTRODUCTION 
Neurofibromatosis type 1 (NF1), or yon 
Recklinghausen neurofibromatosis, is one of 
the most common autosomat dominant disor- 
ders in man. It is characterized by abnormal- 
ities that primarily affect tissues derived from 
the neural crest, including multiple neurofi- 
bromas, cafe-au-lait spots, axillary freckling, 
Lisch nodules, distinct bony lesions, and 
optic nerve glioma (1). Early linkage analysis 
demonstrated that the locus for NF1 resided 
on chromosome 17 (2, 3). The identification 
of two NF1 patients with chromosome 17 
translocations expedited the identification of 
the gene for this disease (4-6). Further 
chromosomal and cDNA walking culminated 
in the construction of the entire NF1 coding 
sequence (7). Analysis of the 2818 amino 
acid open reading frame demonstrated se- 
quence similarity between a small central 
portion of NF1 and a family of GTPase- 
activating proteins (GAPs) (8). FunctionaI 
homology to GAP has been demonstrated 
using biochemical assays of RAS-GTP hydro- 
lysis as well as by functional complementa- 
tion studies in yeast (9-11). 
The protein product of the NF1 locus 
has recently been identified (12, 13). Using 
antibodies generated against fusion proteins 
and synthetic peptides, a unique 250-kDa 
protein was found in all tissues and cell lines 
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examined; however, the highest levels of 
expression were in brain, spleen, and kidney. 
The NF1 gene product was originally termed 
NF1-GAP-related protein (NF1GRP) to 
emphasize the relationship between NF1, 
mammalian GAP (14), and the yeast IRA1 
and IRA2 genes (15), but is now called 
neurofibromin. This protein was localized to 
the cytoplasm by differential centrifugation 
and by glycerol gradients (13). Furthermore, 
unlike GAP, which is phosphorylated on 
tyrosine residues in response to growth 
factor stimulation, neurofibromin is instead 
heavily phosphorylated on serine and threo- 
nine residues (16). In order to identify the 
subcellular localization of neurofibromin, 
indirect immunofluorescent analyses were 
performed using anti-neurofibromin antibod- 
ies. This paper describes the unexpected 
association of neurofibromin with microtu- 
bules, suggesting that neurofibromin may be 
involved in microtubule-mediated signal 
transduction pathways. 
MATERIALS AND METHODS 
Generation of' Antibodies. Anti-neuro- 
fibromin antibodies were produced by hyper- 
immunizing rabbits with either the synthetic 
G peptide (residues 1400-1419 of the full- 
length NF1 translated cDNA sequence) 
conjugated to keyhole limpet hemoglobin 
(KLH; 13:1 coupling ratio) or fusion proteins 
containing portions of the NF1 cDNA sub- 
cloned into the pMAL expression vector 
system (New England BioLabs) (17). The 
generation of the pMAL.B3A antiserum has 
been previously described (12). Antiserum 
was precipitated in 33% ammonium sulfate 
and extensively dialyzed against PBS. After 
dialysis, the fusion protein antiserum was 
absorbed twice overnight with pMAL.c fu- 
sion protein immobilized onto nitrocellulose 
filters to remove antibodies directed against 
the maltose binding protein portion of the 
fusion protein. The mouse monoclonal GAP 
antibody (B4F8) was purchased from Santa 
Cruz Biotechnology. 
Immunofluorescence. Cells grown on 
glass cover slips were rinsed with PBS and 
then fixed in -20°C methanol for 5 min. Cells 
were subsequently rehydrated with PBS. 
Primary antibodies (anti-neurofibromin or 
mouse monoclonals) were diluted 1:100 in 
DMEM media containing 10% fetal calf 
serum and incubated for 1 h at 37°C in a 
humidified chamber. The cover slips were 
then rinsed in PBS and secondary antibodies 
[affinity-purified fluorescein-conjugated goat 
anti-rabbit or rhodamine-conjugated goat 
anti-mouse (Boehringer Mannheim)] were 
diluted 1:200 in media and incubated on 
cover slips for 30 min at 37°C and then 
washed three times in PBS. Nuclei were 
counterstained with propidium iodide (2 
ng/ml) for 3 min. Cover slips were washed 
twice with PBS and mounted in Citifluor. 
Photomicrographs were taken with a Zeiss 
Axiophot microscope using Kodak T-Max 
400 or Ektachrome 400 film. 
Double-labeled samples were analyzed 
using a Nikon Optiphot microscope mounted 
to a laser-scanning confocal imaging system 
(Bio-Rad 600). We obtained a z-series from 
computer assisted images taken simulta- 
neously from two channels. 
Construction of the Homozygous NF1 
Knockout Cell Lines. Using gene targeting 
techniques on embryonic stem (ES) cells, the 
mouse homolog of the human NF1 gene exon 
31 was interrupted by the bacterial neomycin- 
resistance gene, as described by Thomas and 
Capecchi (18). The targeting efficiency was 
high, with approximately one homologous 
recombination per 50 G418-resistant cells. 
Heterozygous ES cell clones were used to 
construct germline chimeras that were subse- 
quently crossed to produce homozygous NF1 
knockout mice (T. Jacks, in preparation). 
Embryonic fibroblast cell lines were estab- 
lished from homozygous NF1 knockout mice 
(182.193-H) and from littermates that were 
NF1 Gene Product Associates with Microtubulcs 267 
homozygous for the wild-type NF1 gene 
(182.193-F). 
Cell Culture. All mammalian cell lines 
(PTKa, NIH3T3, skin fibroblasts and Schwann 
cells) were maintained in DMEM supple- 
mented with 10% fetal calf serum in a 5% 
CO2 atmosphere; however, Sf9 insect cells 
were grown in complete Grace's insect cell 
media at 28°C without CO2. 
Immunoblotting. Microtubule prepara- 
tions were generated by standard microtu- 
bule cycling methods (19). Protein, 100 ~xg, 
from supernatant and enriched microtubule 
fractions (25 p.g protein from Sf9 cells) was 
boiled in standard Laemmli loading buffer, 
separated by 7.5% SDS-PAGE, and trans- 
ferred onto Immobilon filters (Millipore) in 
50 mM Tris HC1, 380 mM glycine, and 10% 
methanol for 2 h at 80-90 V. Membranes 
were blocked for 2 h in 5% Blotto-TBST (20 
mM Tris HCI, pH 7.5, 150 mM NaCl, 0.05% 
Tween-20) prior to overnight incubation with 
1 txg/ml anti-neurofibromin antibody or 
1:1000 dilution of [3-tubulin mouse mono- 
clonal antibody (Sigma). Secondary alkaline 
phosphatase-conjugated anti-mouse (1:2500 
dilution; Promega) or anti-rabbit (1:3000 
dilution; Biorad) antibodies were incubated 
for 1 h and filters were developed using 
5-bromo-4-chloro-3-indolyl phosphate with 
nitroblue tetrazolium (20). 
Preparation of Viral Stocks. Fragments 
of the NF1 gene were cloned into the NheI 
site of the baculovirus transfer vector pBlue- 
Bac (Invitrogen). The construct with the 
GAP-related domain (GRD) consisted of 
the 1.2-kb fragment between nucleotides 
3368 and 4608, while the HF3A fragment 
extends from nucleotide -112 through 4842 
(numbering is relative to + 1 being the start 
of translation) (7). The pl20-GAP construct 
contained a 4.3-kb fragment of the bovine 
p120-GAP gene (21). Virat stocks were 
prepared as previously described (22), in- 
fected cells were lysed and the lysate was 
immunobIotted with neurofibromin or p120- 
GAP antibodies to verify that the correct 
protein was being produced. 
Infection of Cells with Vires. Sf9 cells, 
1.8 × 107, were plated and allowed to attach 
overnight. The cells were then infected with 
virus at a multiplicity of infection of six. After 
infection, the viral solution was removed and 
replaced with complete media. The cells 
were then cultured at 28°C for 48 h. 
Ion Exchange Chromatography. Tubulin 
and MAPs were separated using the method 
described by Vallee (19). Thrice-cycled micro- 
tubule preparations were applied in 0.25 M 
NaC1-Pipes-HCl, pH 6.6, 1 mM EDTA, 1 
mM MgSO4, and 1 mM GTP (PEMG) onto a 
DEAE Sephadex A-50 column. Fractions 
that eluted at 0.25 M NaCI-PEMG and at 0.5 
M NaCI-PEMG were collected separately 
and stored at -70°C in PEM with 1 mM 
GTP. One hundred micrograms of each 
fraction were loaded onto 7.5% SDS- 
polyacrylamide gels and immunoblotted as 
previously described. 
RESULTS 
Immunofluorescent Subcelhdar Localiza- 
tion of Neurofibromm. In order to broaden 
our understanding of neurofibromin func- 
tion, we investigated the subcellular localiza- 
tion of neurofibromin using indirect immuno- 
fluorescence with antibodies. Figure 1A and 
B compares the preimmune and immune 
staining, respectively, of NIH 3T3 cells with a 
polyclonal antibody generated against the 
pMAL.B3A fusion protein (residues 2746- 
2818). The immune staining consistently 
shows that neurofibromin is concentrated in 
the perinuclear region of the cell but can also 
be visualized extending into the cytoplasm. 
The staining reaction could be inhibited by 
preincubation with the purified fusion pro- 
tein (Fig. 1C), thus demonstrating its specific- 
ity. This specificity was further confirmed 
using murine embryonic fibroblasts contain- 
ing a homozygous targeted disruption of the 
NF1 gene. These cells showed only nonspe- 
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Fig. 1. Indirect immunofluorescent analysis demon- 
strates the specificity of anti-neurofibromin antibodies 
using NIH3T3 and NFl-knockout mouse cells. Preim- 
mune rabbit sera gave diffuse, nonspecific background 
staining (A); while the immune sera from that rabbit 
showed a distinct cytoplasmic staining pattern (B). The 
staining could be inhibited by preincubation with 
purified antigen, in this case the pMAL.B3A fusion 
protein (C). All cell nuclei in A-C were counterstained 
with propidium iodide. Embryonic fibroblasts from 
homozygous knockout mice stained with anti-neurofibro- 
rain antibodies exhibit faint, diffuse, nonspecific back- 
ground staining (D), while cells from wild-type litter- 
mates showed a distinct punctate and fibrillar cytoplasmic 
staining pattern (E). 
cific, background staining (Fig. 1D), while 
wild-type littermate cells showed a cytoplas- 
mic staining pattern similar to NIH 3T3 cells 
(Fig. 1E). Moreover, analysis of these two 
cell types using preimmune sera showed no 
specific staining in either cell line (data not 
shown). 
Association of Neurofibromin with Cyto- 
skeletal Elements. Immunofluorescent analy- 
sis of rat kangaroo fibroblasts (PTK1) demon- 
strated a fine fibrillar cytoplasmic staining 
pattern. The fibrillar staining pattern was 
similar to that of a cytoskeletal element. 
Double-label indirect immunofluorescence 
analyzed by laser scanning confocal micros- 
copy demonstrated that neurofibromin is 
localized within punctate perinuclear bodies 
and along microtubules (Fig. 2). A z-series of 
0.5-~m images showed that neurofibromin 
(Fig. 2A) and cytoplasmic microtubules 
(tubulin; Fig. 2B) were associated through- 
out the ceil. Interestingly, neurofibromin was 
never observed in association with either 
spindle microtubules or midbodies. Further- 
more, the staining pattern showed no rela- 
tion to actin filaments in any of the cells 
examined (data not shown). An antibody 
generated against a peptide from a spatially 
different portion of the molecule (H;12) also 
decorated the microtubules (data not shown). 
To further characterize the relationship 
between neurofibromin and microtubules, 
cells were treated with antimitotic drugs that 
cause the disassembly of most microtubules. 
Exposure of cells to colcemid, nocodazole, or 
griseofulvin resulted in the dissolution of 
cytoplasmic microtubules and the simulta- 
neous disaggregation of neurofibromin stain- 
ing (data not shown). When cells treated 
with colcemid were allowed to recover and 
the microtubules had reassembled, neurofi- 
bromin also returned to its original localiza- 
tion pattern (data not shown). 
Despite the punctate appearance of the 
neurofibromin immtmofluorescence pattern, 
these antibodies did not appear to be 
recognizing any particular cellular organelle. 
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Fig. 2. Neurofibromin colocatizes with cytoplasmic microtubules by double-label indirect immunofluorescence. The 
similarity between the staining pattern of neurofibromin and microtubules can best be appreciated with double 
immunofluorescent staining. The same PTKI cell was stained with both anti-neurofibromin antibodies (pMAL.B3A 
antiserum) and monoclonal 13-tubulin antibodies (Sigma). Neurofibromin was detected with an FITC-labeled 
secondary antibody (A), while the microtubules were detected with a rhodamine-labeled secondary antibody (B). A z 
series of 0.5-~m optical sections was obtained using laser scanning confocal microscopy. The image demonstrates 
that neurofibromin localization is aligned with microtubules throughout the cell. This association is particularly 
evident in areas of microtubule bundles. The nuclear counterstain is apparent on the rhodamine channel (B). 
To determine whether  the neurofibromin 
antibodies cross-reacted with a protein within 
an organelle, pr imary human fibroblasts were 
labeled with antibodies against mitochondria 
(Chemicon),  Golgi complex (Chemicon), 
and  e n d o p l a s m i c  r e t i c u l u m  and the  
p M A L B 3 A  neurofibromin antibody. None 
of the organelle-specific antibodies recog- 
nized the same structures as the pMAL.B3A 
antibody (data not shown). 
Neurofibromin is Enriched in Microtubute- 
Containing Preparations. To provide biochem- 
ical confirmation of the indirect immunofluo- 
rescence observation that  neurofibromin 
associates with microtubules, in vitro assem- 
bled microtubule preparat ions from rat brain 
were examined by western immunoblotting. 
As shown in Fig. 3A, enriched microtubute, 
but not supernatant,  fractions contain neuro- 
fibromin and [3-tubulin. Immunoblot t ing of 
identical P V D F  membranes  with mono- 
clonal antibodies directed against MAP1 or 
MAP2 demonstra ted similar copurification 
patterns as those seen with neurofibromin 
(data not shown). However,  p120-GAP was 
not enriched in the microtubule fractions 
and could be detected in both the superna- 
tant and microtubule fractions (data not 
shown). 
Ion exchange chromatography was per- 
formed in order  to determine whether  
neurofibromin could be eluted from a DEAE-  
Sephadex A-50 column in the same fashion 
as other proteins which associate with micro- 
tubules. Figure 3B shows that both neurofi- 
bromin and MAP2 elute from micrombule  
preparat ions with 0.25 M NaC1 by D E A E  ion 
exchange chromatography,  whereas tubulin 
is eluted with 0.5 M NaC1. 
Localization of Domain Responsible .[or 
Neurofibromin-MicrotubuleAssociation. In an 
effort to determine which region(s) of neuro- 
fibromin associate(s) with microtubules, por- 
tions of the NF1 gene were expressed in Sf9 
insect cells and assayed for their ability to 
copurify with insect cell microtubules by in 
vitro microtubule assembly. As can be seen in 
Fig. 4A, both the GAP-rela ted domain, as 
well as the amino terminal portion of 
neurofibromin (which contains the GRD) ,  
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Fig. 3. lmmunoblotting of microtubule-enriched fractions demonstrates the presence of neurofibromin and its 
separation by ion-exchange chromatography. (A) One hundred micrograms of protein from either the supernatant 
(S) or microtubule-containing (MT) fractions obtained by repeated cycling of rat brain homogenates were separated 
by 7.5% SDS-PAGE prior to transfer to PVDF membranes and immunobtotting with neurofibromin antibodies (G1; 
1:200) and [3-tubulin antibodies (1:1000). MT1 = microtubule fractions; $1 = supernatant fraction. (B) One hundred 
micrograms of protein from either the 0.25 M NaCl fractions or the 0.5 M NaC1 fractions from thrice-cycled rat brain 
microtubules were separated by 7.5% SDS-PAGE prior to transfer to PVDF membranes and immunoblotting with 
neurofibromin antibodies (1:200), MAP2 antibodies (1:1000), and B-tubulin antibodies (1:1000). Development was 
performed using anti-mouse or anti-rabbit alkaline phosphatase-conjugated secondary antibodies as described in the 
Materials and Methods. 
copurify with polymer ized  microtubules  dur- 
ing cycling. This is in contras t  to the results 
obta ined  f rom microtubule  cycling experi- 
ments  using Sf9 cells expressing full-length 
G A P  (Fig. 4B), in which p120-GAP was 
enr iched  in the superna tan t  but  not  the 
microtubule  fraction. Coexpression of  neuro-  
f ibromin ( G R D  or H F 3 A )  and p l 2 0 - G A P  in 
Sf9 cells did not  alter their  respective 
microtubule  localization pat terns  (data  not  
shown). 
D I S C U S S I O N  
T he  recent  cloning of  the gene for von 
Reckl inghausen neurof ibromatosis  has made  
it possible to design experiments  that  analyze 
the funct ion of  its gene product .  The  genera-  
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Fig. 4. Immunobtotting of microtubule-enriched frac- 
tions in Sf9 insect cells expressing neurofibromin 
demonstrates the presence of neurofibromin. Protein 
(25 ~g) was analyzed from the supernatant (S1) or 
microtubule (MT1) fractions from one cycle of microtu- 
bule assembly of Sf9 cell lysates. Protein from Sf9 ceils 
that express either a portion of the neurofibromatosis 
gene (A) or pl20-GAP (B) were separated by 7.5% 
SDS-PAGE. After transfer to PVDF membranes, 
immunoblotting was performed with 13-tubulin mono- 
clonal antibody (1:1000), rabbit anti-neuroflbromin 
antibody (1 ~g/ml), or monoclonal GAP antibody 
(1:1000). The portions of the neurofibromin protein 
associated with the microtubule pellet while GAP 
remained in the supernatant. GRD = GAP-related 
domain (amino acids 1123-1536); HF3A = amino 
terminal portion of neurofibromin (amino acids I-t614). 
tion of antibodies that recognize the NF1 
gene product (neurofibromin) was an impor- 
tant step toward understanding its func- 
tion(s). Using double-indirect immunofluo- 
rescence, neurofibromin has been localized 
to the cytoplasmic compartment of the cell; 
furthermore, double-labeling shows that it 
associates with microtubules. The postulated 
association of neurofibromin with microtu- 
bules is further supported by in vitro microtu- 
bule assembly experiments. Further confirma- 
tion of this association is provided by the 
demonstration that portions of neurofibro- 
min expressed in insect Sf9 cells likewise 
associate with microtubules. The experi- 
ments with baculovirus-expressed neurofibro- 
min fragments indicate that the residues 
responsible for microtubule interaction re- 
side within the GAP-related domain seg- 
ment. These data strongly suggest that there 
are specific interactions between neurofibro- 
min and microtubules. Similar results have 
been obtained using baculovirus-expressed 
full-length neurofibromin in Sf9 cells (23). 
Although neurofibromin associates and 
copurifies with microtubules, it is premature 
to classify it as a microtubule-associated 
protein (MAP) (24-26). To this end, our 
neurofibromin antibodies do not recognize 
MAP1, MAP2, or tau (data not shown). The 
immunofluorescent staining pattern suggests 
that the microtubules are decorated by 
aggregates of neurofibromin. The possibility 
that neurofibromin is part of a larger 
complex or even a small organelle has not 
been ruled out. Some cellular organelles can 
copurify with microtubules in the same 
fashion as MAPs. However, the staining 
pattern obtained with neurofibromin antibod- 
ies does not resemble the pattern obtained 
with antibodies directed against mitochon- 
dria, Golgi apparatus, or endoplasmic reticu- 
tum. It is important to distinguish between 
bona fide MAPs, which directly interact with 
and play an intrinsic role in stabilizing 
microtubules or facilitating microtubule- 
mediated transport, and other proteins that 
associate with microtubules but lack these 
properties. Further studies are needed to 
clearly define the biochemical nature of 
neurofibromin's interaction with microtu- 
bules before neurofibromin can be defini- 
tively classified as a MAP. However, the 
present results suggest that neurofibromin, 
unlike pl20-GAP, has a physical association 
with microtubules, and this association may 
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have important implications in understand- 
ing its role in signal transduction pathways. 
The association of MAPs with tubulin is 
mediated by at least two different motifs. 
MAP2 (27), tau (28), and bovine adrenal 
190-kDa MAP (29) contain a specific 18 
amino acid sequence (containing Pro-Gly- 
Gly and repeated 1-4 times) that is a key 
component of the tubulin binding domain. 
MAPIB contains no such domain, however, 
and its tubulin binding has been defined as a 
basic region of the protein containing multi- 
ple copies of the motif KKEE or KKE I/V 
(30). The molecular basis for the association 
between neurofibromin and tubulin may be 
quite different than that for MAP1B, MAP2, 
or tau, since no homology to the 18 amino 
acid repeat or the KKEE or KKE I/V motifs 
are present in the amino acid sequence of 
neurofibromin. However, careful sequence 
comparison reveals a 20 amino acid domain 
within neurofibromin, which is homologous 
to a segment near the C-terminal end of both 
MAP2 and tau (Fig. 5). Tau contains a 
central serine (Ser-409) within this homolo- 
gous region that has been shown to be a 
substrate for phosphorylation (31). Further- 
more, the phosphorylated form no longer 
binds to microtubules. The GRD construct 
expressed in baculovirus did not include the 
20 amino acid motif; therefore, this serine- 
containing region is not required for associa- 
tion with microtubules. However, the possibil- 
ity that neurofibromin may have a role in 
regulation of this interaction cannot be 
excluded at this time. 
Our data demonstrate that neurofibro- 
min is a GAP that associates with microtu- 
bules and suggests several hypotheses that 
explain its function, any of which would give 
this protein a unique role in regulation of celt 
division and/or differentiation. One model, 
which fits an "upstream" view of ras-GAP 
interactions (32), suggests that neurofibro- 
min activity is regulated via phosphorylation 
by MAP kinases, such as the ERK family (33, 
34). In this model, neurofibromin would be 
active as a GAP while associated with 
MAP2 [ m 
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Fig. 5. A small region of neurofibromin shares a 
potential serine phosphorylation sequence with tau and 
MAP2. Local sequence similarities among MAP2, 
neurofibromin, and tan were identified using the 
BLAST3 program (38). The MACAW program (39) was 
used to estimate the significance of this three-way 
alignment and the probability that the three sequences are 
related by chance is ~ 10 -12. To assess the specificity of this 
20-residue segment, a quantitative search "profile" (40) 
was constructed and used to search the protein se- 
quence data bases using the PROFILESEARCH 
program (Genetics Computer Group, Inc.). This profile 
identifed MAP2, neurofibromin, and tau with Z-value 
scores > 17. All other known proteins gave Z-value 
scores <10, Phosphorylation of the central serine 
residue has been shown to play an important role in 
interactions between tau and microtubules (31). The 
total number of amino acids in each protein is indicated 
in the top portion of the figure, which also indicates the 
location (black box) of the motif. In the bottom portion, 
the number indicates the residue of the rightmost 
leucine for each protein. 
microtubules, keeping ras in its inactive 
GDP-bound form and inhibiting cell division. 
After phosphorylation by a MAP kinase 
(perhaps on Ser-825; see Fig. 5), neurofibro- 
min might dissociate from microtubules and 
its GAP activity would be reduced or altered. 
As suggested by recent experiments, the 
association of neurofibromin with tubulin 
may reduce its ability to function as a GAP 
(23). This would provide a very different 
pathway for m s  regulation than that of 
mammalian p120-GAP, which is down- 
regulated by tyrosine phosphorylation medi- 
ated through its SH2 and SH3 domains (35). 
A "downstream" model for r a s - G A P  
interactions (32) would suggest that neurofi- 
bromin is induced by the process of ras-GTP 
to ras -GDP conversion to transmit a differen- 
tiation signal through its influence on micro- 
tubule organization. Recently, it has been 
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shown that both cessation of proliferation 
and extension of neurites in the retinoic 
acid-induced ceil line P19 are dependent 
upon MAP2 expression (36). Could neurofi- 
bromin play a similar role, and if so, could its 
loss by mutation in neurofibromatosis lead to 
continued cell division and failure to differen- 
tiate (i.e., tumor formation)? Regardless of 
which of these models proves to have merit, 
the demonstration that neurofibromin is a 
GAP that associates with microtubules is an 
unexpected turn of events. Given the large 
size of the protein (7) and its high degree of 
cross-species conservation (37), it will not be 
surprising if additional functions are defined 
with further analysis. 
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